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Abstract 
Introduction: In June 2009, the World Health Organization declared an influenza pandemic associated with the pandemic (H1N1) 2009 
strain. It was summer in the northern hemisphere, and therefore travelling and vacation time, which also provided an increased opportunity 
for the dissemination of respiratory diseases. 
Methodology: We reviewed the paper case report forms from all the patients with influenza-like illnesses with nasopharyngeal samples 
submitted for laboratory diagnosis of pandemic (H1N1) 2009 infection during the first wave of pandemic influenza that occurred between 
June and August 2009, in the central region of Portugal. 
Results: From all the patients with influenza-like illnesses, one third was found positive for pandemic (H1N1) 2009. Individuals under the 
age of 29 (75%) were the most affected.  
Most of the patients (91%) presented with fever. A group of symptoms were positively correlated with the probability of pandemic (H1N1) 
2009 infection: cough, epistaxis, lack of dyspnea or vomiting, fever, headache and myalgia.  
Conclusions: During the first wave of the pandemic influenza, young individuals were the most affected, and in the ambulatory setting, 
presentation was of a mild febrile illness without complications. 
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Introduction 
The media reported several outbreaks of 
influenza-like illness in Mexico occurring in different 
regions of the country in April 2009 [1]. Later, the 
first confirmed human cases of swine-origin 
influenza A (H1N1) virus infection in the southern 
states of Texas and California, close to the Mexican 
border, were described in the United States of 
America [2].  
A rapid spread of the infection occurred 
thereafter reaching different regions of the world and 
documentation of human-to-human transmission of 
the virus in at least three countries in two of the six 
world regions defined by the World Health 
Organization (WHO) prompted the organization to 
raise the pandemic level from 5 to 6 and to declare an 
influenza pandemic [3]. 
Influenza pandemics have been known to cause 
multiple waves of morbidity and mortality over a few 
months or years although the cause of the wave 
behaviour of influenza pandemics is not precisely 
understood.  
In the northern hemisphere, the pandemic 
developed during the spring and summer months, a 
time when many people are travelling and 
vacationing, which therefore  also presented an 
increased opportunity for the dissemination of 
respiratory diseases. 
This study analyzed the clinical manifestations of 
influenza-like illnesses with samples submitted for 
laboratorial diagnosis of pandemic (H1N1) 2009 
virus infection in the ambulatory setting during the 




Oropharyngeal and nasopharyngeal swabs were 
collected and submitted for laboratory diagnosis of 
pandemic (H1N1) 2009 virus infection in all patients 
with a clinical picture that fulfilled the adopted case 
definition of influenza-like illness: sudden onset of 
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fever (temperature ≥ 38,0 ºC), or history of fever in 
the last few days, and at least two of the following 
symptoms: cough, headache, sore throat, 
myalgia/arthralgia, rhinorrhea, vomiting, diarrhea 
and/or severe acute respiratory disease (including 
pneumonia) suggesting an infectious etiology. Also, 
the existence of an epidemiologic link defined as a 
stay or residence in an area where there was registry 
of transmission in the community of pandemic 
(H1N1) 2009 virus infection, during the seven days 
prior to the beginning of symptoms [4], was 
recorded. 
Laboratory diagnosis of pandemic (H1N1) 2009 
virus infection was performed by a real-time reverse-
transcriptase polymerase-chain-reaction (RT-PCR) 
assay in agreement with the protocol established by 
the WHO [5]. 
We analyzed all the paper case report forms used 
for standardized data collection of the clinical 
manifestations of all patients with influenza-like 
illnesses who presented for medical observation in 
the various ambulatory care points in the central 
region of Portugal. All patients had samples 
submitted for laboratory diagnosis of pandemic 
(H1N1) 2009 infection during the first pandemic 
wave that started on 16 June 2009 (diagnosis of the 
first laboratory-confirmed infection) and ended on 28 
August 2009, with an abrupt drop in new infections. 
 
Statistical analysis 
Variables were summarized as means and 
standard deviation or as median and interquartile 
range. For categorical variables, the percentages of 
patients in each category were calculated. The 
clinical features were compared between subgroups 
of patients infected versus non-infected with the 
pandemic (H1N1) 2009 virus using the Student’s t-
test, Chi-square test, or Fisher’s exact test, as 
indicated. A multiple logistic-regression model was 
used considering the significant variables (p < 0.1) on 
the bivariate analysis to identify independent 
predictive factors associated with pandemic (H1N1) 
2009 virus infection. Results are reported as odds 
ratios (OR) and 95% confidence intervals (95% CI). 
For the multivariate analysis, the p value of the 
model, validity index, and area under the curve 
(AUC) of the receiver operating characteristic (ROC) 
model was calculated.  
A two-sided p value of less than 0.05 was 
considered to indicate statistical significance. All 
statistical analysis was performed with the use of 
SPSS software (Statistical Package for Social 
Sciences, release 16. SPSS Inc., Chicago IL, USA). 
 
Results 
Samples from 828 patients with influenza-like 
illness were consecutively collected and submitted 
for diagnosis of pandemic (H1N1) 2009 virus, by 
RT-PCR. Infection with pandemic (H1N1) virus was 
confirmed in 255 (30.8%) cases. 
 
Demographic data 
The overall median age of the patients was 23 
years (IQR, 13-35 years; range, 21 days to 88 years). 
Infected patients with pandemic (H1N1) 2009 virus 
infection had a lower median age [21 years (IQR, 16-
27; range, 1 month to 84 years)].  
Males (56%; 316 cases) were predominant. The 
distribution by age categories and pandemic (H1N1) 
2009 virus infection showed a significant association 
(p = 0.001). Individuals from 20 to 29 years of age 
included 42.7% (109 cases) of the pandemic (H1N1) 
2009 virus infected patients.  
The proportion of non-infected to pandemic 
(H1N1) 2009 virus infected patients was greater in all 
the categories except ages 10 to 19 years and 20 to 29 
years, with both representing 66.6% (170 cases) of all 
confirmed cases. 
A small proportion of patients (11%; 28 cases) 
with pandemic (H1N1) 2009 virus infection were 
over 40 years old and only 12.2% (31 cases) were 
less than 10. Children under two years old 
represented 2.7% (7 cases) of the total number of 
patients with confirmed infection. 
 
Clinical manifestations 
Overall, 86% of the patients had fever (Table 1), 
which was more common (91%) in patients with 
confirmed pandemic (H1N1) 2009 virus infection 
than in negative patients (84%), (p = 0.009). Fever 
appeared simultaneously with other symptoms in 
66% of the cases. In 31% of these cases fever 
appeared after other manifestations, both in patients 
with a positive test and also in cases negative for 
pandemic (H1N1) 2009 virus (p = 0.854). Fever was 
the first manifestation in only 3% of cases. 
Other commonly reported signs and symptoms 
included myalgia (67%), cough (61%), headache 
(59%), sore throat (52%), rhinorrhea (32%), vomiting 
(16.6%) and diarrhoea (21%).  
Bivariate analysis showed that pandemic (H1N1) 
2009 virus infected patients were more likely to have  
 





fever (90.6% versus 83.7%; p = 0.009), cough 
(81.6% versus 51.7%; p = 0.000), headache (64.3% 
versus 56.6%; p = 0.038), rhinorrhea (37.3%, versus 
29.4%; p = 0.025), and sneezing (20.0% versus 
11.5%; p = 0.000). However, they were less likely to 
have dyspnea, vomiting and diarrhoea than patients 
with a negative result for pandemic (H1N1) 2009 
virus. Also, patients with pandemic (H1N1) 2009 
virus infection had a greater median number of 
symptoms (5 symptoms versus 4, p = 0.000). 
The assessment of the severity of the clinical case 
was made by the attending physician in the first 
appointment and the majority (80%) of cases was 
considered of low severity. During the period 
considered in our study, no patients had pneumonia 
or were admitted to an intensive care unit.  
 
Factors associated with pandemic (H1N1) 2009 virus 
infection 
A multiple logistic regression analysis model was 
used to study the covariates with significant 
association (p < 0.1) in the bivariate analysis: age, 





sneezing, fever, myalgia, vomiting, diarrhea, nausea, 
number of symptoms and epidemiologic link. 
The non-significant variables (rhinorrhea, 
sneezing, diarrhea, nausea, number of symptoms and 
epidemiologic link) were removed to obtain an 
optimized model (greatest p value considered for 
backward regression) (Table 2). This model showed 
that the probability of having laboratory-confirmed 
pandemic (H1N1) 2009 virus infection decreased 
with age (OR, 0.982; 95% CI, 0.971 to 0.993; p = 
0.001); was higher in patients with cough (OR, 4.450; 
95% CI, 3.082 to 6.425; p = 0.000), epistaxis (OR, 
3.855; 95% CI, 1.034 to 14.372; p = 0.044), fever 
(OR, 1.840; 95% CI, 1.106 to 3.060; p = 0.019), 
headache (OR, 1.451; 95% CI, 1.024 to 2.057; p = 
0.036), and myalgia (OR, 1.491; 95% CI, 1.014 to 
2.194; p = 0.042); and was lower in patients with 
dyspnea (OR, 0.418; 95% CI, 0.198 to 0.881; p = 
0.022) and vomiting (OR, 0.463; 95% CI, 0.288 to 
0.744; p = 0.001). 
The p value and the area under the curve of the 
receiver operating characteristic (ROC) proved the 





(n = 828) 
(H1N1) 2009 
Non-confirmed H1N1 
(n = 573) 
Confirmed 
(n = 255) 
 
p value 
 n (%) n (%) n (%)  
Cough 504 60.9% 296 51.7% 208 81.6% <0.001 (*) 
Headache 488 59.0% 324 56.6% 164 64.3% 0.038 (*) 
Sore throat 431 52.1% 294 51.4% 137 53.7% 0.536 (*) 
Rhinorrhea 263 31.8% 168 29.4% 95 37.3% 0.025 (*) 
Dyspnea 56 6.8% 46 8.0% 10 3.9% 0.029 (*) 
Epistaxis 12 1.5% 5 0.9% 7 2.7% 0.055 (**) 
Sneezing 117 14.1% 66 11.5% 51 20.0% 0.001 (*) 
Fever 710 85.9% 479 83.7% 231 90.6% 0.009 (*) 
Myalgia 552 66.7% 370 64.7% 182 71.4% 0.059 (*) 
Arthralgia 176 21.3% 114 19.9% 62 24.3% 0.155 (*) 
Vomiting 137 16.6% 109 19.1% 28 11.0% 0.004 (*) 
Diarrhoea 173 20.9% 133 23.3% 40 15.7% 0.014 (*) 
Nausea 94 11.4% 73 12.8% 21 8.2% 0.058 (*) 
Conjunctivitis 34 4.1% 22 3.8% 12 4.7% 0.565 (*) 
        






(*) Chi-square test        (**) Fisher's exact test 
 




laboratory-confirmed pandemic (H1N1) 2009 virus 
infection. 
The strength of association between symptoms 
and pandemic (H1N1) 2009 infection was not equally 
distributed (see odds ratios described above and in 
Table 2). The presence of cough (OR, 4.450), 
epistaxis (OR, 3.855), fever (OR, 1.840), headache 
(OR, 1.451), and myalgia (OR, 1.491) were strongly 
associated with the probability of having pandemic 
(H1N1) 2009 virus infection. The presence of 
dyspnea (OR, 0.418) and the presence of vomiting 
(OR, 0.463) were negatively associated with the 
probability of pandemic (H1N1) 2009 infection. 
Thus, in the ambulatory setting, an increased 
probability of pandemic (H1N1) 2009 infection 
would be expected with 95% confidence, when 
associated with the presence of cough (3.082 to 6.425 
times), epistaxis (1.034 to 14.372 times), fever (1.106 
to 3.060 times), headache (1.024 to 2.057 times), and 
myalgia (1.014 to 2.194). 
 
Discussion 
We analyzed the clinical characteristics of the 
group of patients with pandemic (H1N1) 2009 virus 
infection diagnosed between June and August, 2009, 
in the central region of Portugal. During the first 
wave of the pandemic, the positivity rate for 
pandemic (H1N1) 2009 virus infection represented 
31% of the group of patients presenting with 
influenza-like illnesses in the ambulatory setting but 
this infection rate was higher than in other regions of 




However, the incidence rate of influenza-like 
illness with a negative result for pandemic (H1N1) 
2009 infection was very high (69%). This occurrence 
could be related to the circulation of other respiratory 
viruses in the community and to the strict isolation 
procedures implemented at that phase of the 
pandemic. 
Vaccines against pandemic influenza were not 
widely available during its first wave and oseltamivir 
therapy and prophylaxis were used extensively as a 
strategy against pandemic influenza.  Antivirals 
reduce the ability of the virus to replicate and do not 
provide immunity to the host but can form a critical 
component for the containment of the pandemic. It 
has been shown that they may aid in the prevention 
of infection, but may also reduce the level of its 
transmission and the severity of the associated 
disease [6]. It is unknown, however, how effective 
these interventions were in decreasing the infection 
rates. School closure for the summer term may have 
had an impact on the spread of disease, but on the 
other hand, summer vacation and travel activities 
could have had an important role in the dissemination 
of the infection. 
In the central region of Portugal, young adults 
were the most affected by the pandemic (H1N1) 2009 
infection, with a median age of 21 years. The 
distribution of the infection by categories according 
to age showed that 89% of the patients were less than 
29 years old. Specific incidence rates for pandemic 
(H1N1) 2009 infection were greater in the age 
categories of 10 to 19 years (25.5%) and 20 to 29 
years (35%); the distribution by age categories 
 Multiple logistic regression Multiple logistic regression: optimized model 
Dependent 
variables 
OR p value 
95% CI for 
OR 
OR p value 
95% CI for 
OR 
Age 0.983 0.002 [0.972; 0.994] 0.982 0.001 [0.971; 0.993] 
Cough 4.177 <0.001 [2.684; 6.500] 4.450 <0.001 [3.082; 6.425] 
Headache 1.482 0.097 [0931; 2.360] 1.451 0.036 [1.024; 2.057] 
Dyspnea 0.421 0.031 [0.192; 0.926] 0.418 0.022 [0.198; 0.881] 
Epistaxis 4.062 0.043 [1.046; 15.777] 3.855 0.044 [1.034; 14.372] 
Fever 1.693 0.070 [0.958; 2.992] 1.840 0.019 [1.106; 3.060] 
Myalgia 1.525 0.103 [0.918; 2.536] 1.491 0.042 [1.014; 2.194] 
Vomiting 0.514 0.014 [0.302; 0.875] 0.463 0.001 [0.288; 0.744] 
Diarrhoea 0.706 0.151 [0.439; 1.135] - - - 
Nausea 0.845 0.602 [0.450; 1.588] - - - 
Number of 
symptoms 
1.005 0.9661 [0.791; 1.276] - - - 
p value (model) < 0.001 < 0.001 
Area under ROC  0.734 0.726 
Overall Percentage 71.0% 71.7% 
Table 2. Analysis of factors associated with pandemic influenza A (H1N1) infection by multiple logistic regression 
 
OR: Odds Ratio            95% CI: 95% Confidence Interval 
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observed in our region was similar to those reported 
in other countries and regions [7,8,9]. 
For the patients with pandemic (H1N1) 2009 
virus infection, fever (91%) was the most common 
manifestation, being followed by cough (81.6%), 
myalgia (71.4%), headache (64.3%) and sore throat 
(53.7%). These manifestations appeared in similar 
proportions to those described in other European 
countries and the Unites States of America [9, 10, 
11]. Manifestations such as diarrhoea and apyrexia 
were described in a greater proportion of patients 
from Asian countries. However, similar but not equal 
case definitions for influenza-like illness were used 
and the values admitted for fever were different, 
making comparisons a difficult task [8].  
According to the data found in our study, 
influenza-like illness with pandemic (H1N1) 2009 
virus infection was associated with a greater number 
of symptoms (5 symptoms versus 4, p = 0.000). Also, 
some of the symptoms were predictors of a greater 
probability of infection. The strength of association 
between symptoms and pandemic (H1N1) 2009 
infection was not equally distributed. Some of the 
symptoms were positively correlated with the 
probability of having pandemic (H1N1) 2009 virus 
infection, namely cough, epistaxis, fever, headache, 
and myalgia. In our study, lack of dyspnea or 
vomiting predicted a greater probability of having 
pandemic (H1N1) 2009 infection compared to the 
patients who had dyspnea or vomiting; we have to 
stress that all the cases included in our study 
presented as mild febrile illnesses without 
complications and that other viruses were also 
circulating at the time. 
Our results may contribute to a more accurate 
case definition of influenza-like illness in future 
influenza pandemics in which a different weight or 
score should be attributed to different symptoms to 
predict those patients most likely to be infected. 
However, the accuracy may depend on the proportion 
of other infections associated with influenza-like 
illnesses circulating in the community. As was 
expected, the sensitivity of the case definition for 
influenza-like illness used rose during the winter 
months when most cases of influenza-like illnesses 
were associated with pandemic (H1N1) 2009 virus 
infection (data not shown). 
The severity of the disease during the first wave 
of pandemic (H1N1) 2009 virus infection observed in 
our region was low, similar to that described in other 
countries [12]. There were no cases of pneumonia, 
respiratory failure requiring ventilator support, or 
deaths during the first wave of pandemic (H1N1) 
2009 virus infection. 
To conclude, in the central region of Portugal, the 
first wave of pandemic (H1N1) 2009 virus infection 
was associated with cases of low severity occurring 
most often in patients younger than 29 years. Also, 
the incidence rate for pandemic influenza was lower 
than that of other common febrile illnesses regularly 
observed during summer months. Probably, early 
diagnosis, use of oseltamivir and strict isolation 
procedures implemented at the time could explain the 
lower proportion of confirmed pandemic (H1N1) 
2009 virus infections in the context of the case 
definition used for influenza-like illness.  
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